http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 18 Aug 2026 16:06:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html si-local-file:///var/storage/secattach/20260818/26944186.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html Tue, 18 Aug 2026 16:06:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html si-local-file:///var/storage/secattach/20260818/26944186.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html Tue, 18 Aug 2026 16:06:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html si-local-file:///var/storage/secattach/20260818/26944186.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+STONE+BENJAMIN/26944186.html Tue, 18 Aug 2026 16:06:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html si-local-file:///var/storage/secattach/20260818/26944164.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html si-local-file:///var/storage/secattach/20260818/26944164.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html si-local-file:///var/storage/secattach/20260818/26944164.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Lizzul+Paul+F./26944164.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html si-local-file:///var/storage/secattach/20260818/26944169.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html si-local-file:///var/storage/secattach/20260818/26944169.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html si-local-file:///var/storage/secattach/20260818/26944169.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++First+Tracks+Biotherapeu++For%3A+Aug+15++Filed+by%3A+Faga+Daniel/26944169.html Tue, 18 Aug 2026 16:05:00 -0400 O.77374830 TRAX TRAX.V http://www.streetinsider.com/New+Coverage/Wolfe+Research+Starts+First+Tracks+Biotherapeutics+%28TRAX%29+at+Outperform/26939775.html <p>Wolfe Research analyst Andy Chen initiates coverage on First Tracks Biotherapeutics (NASDAQ: TRAX) with a Outperform rating and a price target of $83.00.</p><p>The analyst comments "Three assets. The CD122 likely accounts for majority of EV after FBRX acquisition (report). The BDCA2 is early, a small contributor due to new mechanism in a challenging disease (lupus). The PD-1 likely contributing to near-zero in stock due to strong buyside dislike of the RA data. One (CD122), new mechanism in Celiac, not yet clear if better efficacy or equal safety compared to aIL-15. Last week, we previewed argenx's CD122 Ph2 (report), and foresee http://www.streetinsider.com/New+Coverage/Wolfe+Research+Starts+First+Tracks+Biotherapeutics+%28TRAX%29+at+Outperform/26939775.html Tue, 18 Aug 2026 05:39:20 -0400 TRAX http://www.streetinsider.com/Analyst+Comments/Wolfe+Research+Starts+First+Tracks+Biotherapeutics+%28TRAX%29+at+Outperform/26939775.html <p>Wolfe Research analyst Andy Chen initiates coverage on First Tracks Biotherapeutics (NASDAQ: TRAX) with a Outperform rating and a price target of $83.00.</p><p>The analyst comments "Three assets. The CD122 likely accounts for majority of EV after FBRX acquisition (report). The BDCA2 is early, a small contributor due to new mechanism in a challenging disease (lupus). The PD-1 likely contributing to near-zero in stock due to strong buyside dislike of the RA data. One (CD122), new mechanism in Celiac, not yet clear if better efficacy or equal safety compared to aIL-15. Last week, we previewed argenx's CD122 Ph2 (report), and foresee http://www.streetinsider.com/Analyst+Comments/Wolfe+Research+Starts+First+Tracks+Biotherapeutics+%28TRAX%29+at+Outperform/26939775.html Tue, 18 Aug 2026 05:39:20 -0400 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+TCG+Crossover+GP+II%2C+LLC/26931403.html si-local-file:///var/storage/secattach/20260814/26931403.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+TCG+Crossover+GP+II%2C+LLC/26931403.html Fri, 14 Aug 2026 16:31:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+TCG+Crossover+GP+II%2C+LLC/26931403.html si-local-file:///var/storage/secattach/20260814/26931403.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+TCG+Crossover+GP+II%2C+LLC/26931403.html Fri, 14 Aug 2026 16:31:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26925207.html si-local-file:///var/storage/secattach/20260814/26925207.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26925207.html Fri, 14 Aug 2026 08:34:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26925207.html si-local-file:///var/storage/secattach/20260814/26925207.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26925207.html Fri, 14 Aug 2026 08:34:00 -0400 O.77374830 TRAX http://www.streetinsider.com/Earnings/First+Tracks+Biotherapeutics%2C+Inc.+%28TRAX%29+Reports+Q2+Loss+of+%240.95/26921470.html <p>First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX) reported Q2 EPS of ($0.95).</p><p>For earnings history and earnings-related data on First Tracks Biotherapeutics, Inc. (TRAX) <a href="http://www.streetinsider.com/ec_earnings.php?q=TRAX">click here</a>.</p> http://www.streetinsider.com/Earnings/First+Tracks+Biotherapeutics%2C+Inc.+%28TRAX%29+Reports+Q2+Loss+of+%240.95/26921470.html Thu, 13 Aug 2026 16:19:01 -0400 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Affinity+Asset+Advisors%2C+LLC/26921071.html si-local-file:///var/storage/secattach/20260813/26921071.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Affinity+Asset+Advisors%2C+LLC/26921071.html Thu, 13 Aug 2026 16:11:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Affinity+Asset+Advisors%2C+LLC/26921071.html si-local-file:///var/storage/secattach/20260813/26921071.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++First+Tracks+Biotherapeu+++++++++++++++Filed+by%3A+Affinity+Asset+Advisors%2C+LLC/26921071.html Thu, 13 Aug 2026 16:11:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++424B3++++++First+Tracks+Biotherapeu+++++++++++++/26920809.html si-local-file:///var/storage/secattach/20260813/26920809.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++First+Tracks+Biotherapeu+++++++++++++/26920809.html Thu, 13 Aug 2026 16:06:00 -0400 O.77374830 TRAX http://www.streetinsider.com/SEC+Filings/Form++424B3++++++First+Tracks+Biotherapeu+++++++++++++/26920809.html si-local-file:///var/storage/secattach/20260813/26920809.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++First+Tracks+Biotherapeu+++++++++++++/26920809.html Thu, 13 Aug 2026 16:06:00 -0400 O.77374830 TRAX http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2495+at+Piper+Sandler/26916616.html (Updated - August 13, 2026 9:24 AM EDT) <p>Piper Sandler analyst Yasmeen Rahimi raised the price target on First Tracks Biotherapeutics (NASDAQ: TRAX) to $95.00 (from $54.00) while maintaining an Overweight rating.</p><p>The analyst commented: "We had a chance to catch up with TRAX following 2Q26 earnings where they detailed how ANB033's Ph1b CeD Cohort 1 enrollment is complete with data remaining on-track for 4Q26. With this, mgmt explained their rationale behind adjusting the Cohort 2 enrollment to include a Vh:Cd <2.5 (vs <2.0) and any symptoms at baseline in order to evaluate ANB033's effect on mucosal healing in a broader patient http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2495+at+Piper+Sandler/26916616.html Thu, 13 Aug 2026 09:24:17 -0400 TRAX http://www.streetinsider.com/Analyst+Comments/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2495+at+Piper+Sandler/26916616.html (Updated - August 13, 2026 9:24 AM EDT) <p>Piper Sandler analyst Yasmeen Rahimi raised the price target on First Tracks Biotherapeutics (NASDAQ: TRAX) to $95.00 (from $54.00) while maintaining an Overweight rating.</p><p>The analyst commented: "We had a chance to catch up with TRAX following 2Q26 earnings where they detailed how ANB033's Ph1b CeD Cohort 1 enrollment is complete with data remaining on-track for 4Q26. With this, mgmt explained their rationale behind adjusting the Cohort 2 enrollment to include a Vh:Cd <2.5 (vs <2.0) and any symptoms at baseline in order to evaluate ANB033's effect on mucosal healing in a broader patient http://www.streetinsider.com/Analyst+Comments/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2495+at+Piper+Sandler/26916616.html Thu, 13 Aug 2026 09:24:17 -0400 TRAX http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2457+at+H.C.+Wainwright/26916108.html H.C. Wainwright analyst Emily Bodnar raised the price target on First Tracks Biotherapeutics (NASDAQ: TRAX) to $57.00 (from $44.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2457+at+H.C.+Wainwright/26916108.html Thu, 13 Aug 2026 06:55:27 -0400 TRAX http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2465+at+Barclays/26915291.html Barclays analyst Etzer Darout raised the price target on First Tracks Biotherapeutics (NASDAQ: TRAX) to $65.00 (from $48.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/First+Tracks+Biotherapeutics+%28TRAX%29+PT+Raised+to+%2465+at+Barclays/26915291.html Thu, 13 Aug 2026 05:38:10 -0400 TRAX http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++First+Tracks+Biotherapeu++For%3A+Jun+30/26913329.html si-local-file:///var/storage/secattach/20260812/26913329.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++First+Tracks+Biotherapeu++For%3A+Jun+30/26913329.html Wed, 12 Aug 2026 16:25:00 -0400 O.77374830 TRAX